AstraZeneca calls pitch for cholesterol drug Crestor in Hong Kong

HONG KONG - Global pharmaceutical company AstraZeneca has called an integrated agency pitch for its cholesterol-lowering drug Crestor and has already started pitch meetings, with the result expected in Q4.

by Benjamin Li

Please sign in below or access limited articles a month after free, fast registration.

 If you don’t yet have an account, you can register for free to unlock additional content. For full access to everything we offer, view our subscription plans.

Register for free

✓ Access limited free articles each month

✓ Email bulletins – top industry news and insights delivered straight to your inbox

Register now

Subscribe

✓ Unlimited access to all Campaign Asia content

✓ Real-world campaign case studies and career insights

✓ Exclusive reports, industry news, and annual features

Join now